C. Sophia Albott - Concepedia

Author

C. Sophia Albott

University of Minnesota Medical Center ORCID

Also Known As

C S Albott, C Sophia Albott, C. Sophia Albott, C.S. Albott, Christina Sophia Albott, Cristina Albott, Cristina S. Albott, Cristina Sophia Albott, Sophia Albott, Sophia C. Albott

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota Medical Center University of Minnesota Minneapolis VA Health Care System The University of Queensland Geriatric Research Education and Clinical Center

About

C. Sophia Albott is an author at University of Minnesota Medical Center specializing in medicine, depression, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	271
2	Social Sciences	3	3	271
3	Neuroscience	2	2	50
4	Anesthesia	1	1	221
5	Neurology	1	1	11

C. Sophia Albott

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy Lionel Van Maldergem, J. Magre, T. E. Khallouf, Journal of Medical Genetics	2002	247
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression Paulo Shiroma, Brian A. Johns, Michael A. Kuskowski, Journal of Affective Disorders PsychiatryAddictionTreatment Resistant DepressionMedicinePsychotropic Medication	2013	221
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression C. Sophia Albott, Kelvin O. Lim, Miriam K. Forbes, The Journal of Clinical Psychiatry	2018	156
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression Paulo Shiroma, C. Sophia Albott, Brian A. Johns, The International Journal of Neuropsychopharmacology	2014	121
Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study Kathryn R. Cullen, Palistha Amatya, Mark G. Roback, Journal of Child and Adolescent Psychopharmacology	2018	111
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression Paulo Shiroma, Paul Thuras, Joseph Wels, Translational Psychiatry	2020	104
Association of Childhood Adversity With Differential Susceptibility of Transdiagnostic Psychopathology to Environmental Stress in Adulthood C. Sophia Albott, Miriam K. Forbes, Justin J. Anker JAMA Network Open	2018	91
Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression Paulo Shiroma, Paul Thuras, Joseph Wels, Journal of Affective Disorders NeuropsychologyPsychoactive DrugPsychiatryNeurophysiologyTreatment Resistant Depression	2020	39
Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression Abhrajeet Roy, Michelle Thai, Bonnie Klimes‐Dougan, Journal of Psychopharmacology	2020	28
Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression Michelle Thai, Zeynep Başgöze, Bonnie Klimes‐Dougan, Frontiers in Psychiatry	2020	17

Page 1